Paclitaxel-Avelumab for Angiosarcoma

Condition:   Angiosarcoma Metastatic Intervention:   Drug: Avelumab Sponsors:   Sung Yong Oh;   Merck KGaA Not yet recruiting

Source: ClinicalTrials.gov - May 1, 2018 Category: Research Source Type: clinical trials